Natixis Advisors, L.P. Bio Rad Laboratories, Inc. Transaction History
Natixis Advisors, L.P.
- $63 Billion
- Q2 2025
A detailed history of Natixis Advisors, L.P. transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Natixis Advisors, L.P. holds 38,950 shares of BIO stock, worth $11.5 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
38,950
Previous 26,654
46.13%
Holding current value
$11.5 Million
Previous $6.49 Million
44.78%
% of portfolio
0.01%
Previous 0.01%
Shares
14 transactions
Others Institutions Holding BIO
# of Institutions
428Shares Held
19.1MCall Options Held
10.7KPut Options Held
35.5K-
First Eagle Investment Management, LLC2.52MShares$746 Million1.23% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.85MShares$548 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.55MShares$460 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1MShares$296 Million0.06% of portfolio
-
Veritas Asset Management LLP863KShares$256 Million2.27% of portfolio
About BIO-RAD LABORATORIES, INC.
- Ticker BIO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,633,900
- Market Cap $7.3B
- Description
- Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...